1
2
Clinical review report : Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
Erschienen: Ottawa (ON),
Canadian Agency for Drugs and Technologies in Health,
February 2018
Version: final.
3
4
- 1
- [1]